Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Freeman

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Neuroscience and Biobehavioral Reviews|November 14, 1997
Aging in the hippocampus: interrelated actions of neurotrophins and glucocorticoidsR N McLay, S M Freeman, R E Harlan, et al.
Circulation|November 1, 1989
Seeding of intravascular stents with genetically engineered endothelial cellsD A Dichek, R F Neville, J A Zwiebel, et al.
Human Immunology|September 1, 1987
Determination of DR beta 1 alleles of DR4/Dw subtypes by oligonucleotide probingS M Freeman, H J Noreen, C A Dahl, et al.
Neuroscience|May 13, 2014
Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus)S M Freeman, H Walum, K Inoue, et al.
Pharmacology & Therapeutics|April 1, 1995
Gene-modified cells for the treatment of cancerK A Whartenby, G N Abraham, P A Calabresi, et al.
International Journal of Cancer|November 14, 1997
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinomaA J Marrogi, A Munshi, A J Merogi, et al.
Journal of Zoology (London, England : 1987)|July 26, 2016
Distributions of oxytocin and vasopressin 1a receptors in the Taiwan vole and their role in social monogamyA R Chappell, S M Freeman, Y K Lin, et al.
Blood|April 1, 1992
Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous diseaseC S Cobbs, H L Malech, T L Leto, et al.
Cancer Research|November 1, 1993
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modifiedS M Freeman, C N Abboud, K A Whartenby, et al.
Human Gene Therapy|December 16, 1998
The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I studyP Schwarzenberger, L Harrison, A Weinacker, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Neuroscience and Biobehavioral Reviews|November 14, 1997
Aging in the hippocampus: interrelated actions of neurotrophins and glucocorticoidsR N McLay, S M Freeman, R E Harlan, et al.
Circulation|November 1, 1989
Seeding of intravascular stents with genetically engineered endothelial cellsD A Dichek, R F Neville, J A Zwiebel, et al.
Human Immunology|September 1, 1987
Determination of DR beta 1 alleles of DR4/Dw subtypes by oligonucleotide probingS M Freeman, H J Noreen, C A Dahl, et al.
Neuroscience|May 13, 2014
Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus)S M Freeman, H Walum, K Inoue, et al.
Pharmacology & Therapeutics|April 1, 1995
Gene-modified cells for the treatment of cancerK A Whartenby, G N Abraham, P A Calabresi, et al.
International Journal of Cancer|November 14, 1997
Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinomaA J Marrogi, A Munshi, A J Merogi, et al.
Journal of Zoology (London, England : 1987)|July 26, 2016
Distributions of oxytocin and vasopressin 1a receptors in the Taiwan vole and their role in social monogamyA R Chappell, S M Freeman, Y K Lin, et al.
Blood|April 1, 1992
Retroviral expression of recombinant p47phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous diseaseC S Cobbs, H L Malech, T L Leto, et al.
Cancer Research|November 1, 1993
The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modifiedS M Freeman, C N Abboud, K A Whartenby, et al.
Human Gene Therapy|December 16, 1998
The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I studyP Schwarzenberger, L Harrison, A Weinacker, et al.
Pageof 6